How WuXi AppTec's Integrated CRDMO Model Supports Biotechnology Companies from Discovery to IND

Source Summary

Key Takeaways Investigational New Drug (IND) submission requires coordinated decisions across biology, DMPK, bioanalysis, and chemistry, manufacturing, and controls (CMC). WuXi AppTec's (https://www.wuxiapptec.com/)integrated CRDMO (Contract Research, Development and Manufacturing Organization) model connects these functions from early discovery through IND submission. Case